Basit öğe kaydını göster

dc.contributor.authorAkın, Demet
dc.contributor.authorBerk, Scott C.
dc.contributor.authorŞener, Yavuz Ali
dc.contributor.authorKepenek, Ata Onur
dc.contributor.authorÖzdaş, Şule Beyhan
dc.contributor.authorDemircan, Günnur
dc.date.accessioned2019-12-19T10:03:12Z
dc.date.available2019-12-19T10:03:12Z
dc.date.issued2019en_US
dc.identifier.citationAkın, D., Berk, S. C., Şener, Y. A., Ata, O., Özdaş Ş. B. ve Demircan, G. (2019). Trigonelline's effect on BCL-2 protein expression level in THP-1 cells. European Biotechnology Congress içinde (S24-S24. ss.). Valencia, Spain, April 11-13, 2019. https://doi.org/10.1016/j.jbiotec.2019.05.093en_US
dc.identifier.issn0168-1656
dc.identifier.issn1873-4863
dc.identifier.urihttps://doi.org/10.1016/j.jbiotec.2019.05.093
dc.identifier.urihttps://hdl.handle.net/20.500.12511/4545
dc.description.abstractObjective: Trigonelline (TRG), is one of the main constituents of coffee and is an alkaloid derivative of vitamin B6 in plants. TRG has been reported to have antihyperglycemic, antihyperlipidemic, and antioxidant activities. At the same time studies of TRG on cancer and the effect on diabetes have been done. However, there is no study of the effect of TRG on apoptosis in monocytes. In this study, the possible effects of trigonelline on apoptosis on human monocytes were examined. Seven experimental groups were evaluated: (1) the control group treated with the medium (RPMI-1640), (2) the cell group treated with 200 μM H2O2 for 1 hour, (3/4/5/6/7) The cell group treated with 10−5/5 × 10−5/10−4/2,5 × 10−4/5 × 10−4 M TRG for 24 hours and then treated with 200 μM H2O2 for 1 hour (anti- Apoptotic effects). Bcl-2 protein expression levels were measured by western blot. It was observed that TRG significantly reduced Bcl-2 protein expression levels increased by H2O2 (P < 0.005) at all doses given. The results of preliminary experiments reveal the effects of trigonelline, which is involved in autophagic and apoptotic processes. It has been indicated that trigonelline may have a potential role in the prevention and treatment of oxidative stress in monocytes.en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectTrigonellineen_US
dc.subjectAntihyperglycemicen_US
dc.subjectAntioxidant Activitiesen_US
dc.titleTrigonelline's effect on BCL-2 protein expression level in THP-1 cellsen_US
dc.typeconferenceObjecten_US
dc.relation.ispartofEuropean Biotechnology Congressen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesien_US
dc.identifier.volume305en_US
dc.identifier.issueSupplement: Sen_US
dc.identifier.startpageS24en_US
dc.identifier.endpageS24en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.jbiotec.2019.05.093en_US
dc.identifier.wosqualityQ2en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster